Home › Funds › 22NW, LP › ELDN

22NW, LP position in ELDN

ELEDON PHARMACEUTICALS INC · Health Care

22NW, LP reported holding 636,364 shares of ELDN (ELEDON PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$1.6M, representing 1.12% of its reported portfolio and ranking #13 among its reported holdings. 22NW, LP has disclosed ELDN holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)636.36K sh
Reported value held$1.61M
Portfolio Weight1.12%
First reportedQ1 2025
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How 22NW, LP's ELDN position evolved

22NW, LP first disclosed a stake in ELDN in Q1 2025 at 636,364 shares (US$2.2M). The position peaked in Q2 2026 at 636,364 shares, worth US$2.5M. Across 7 filings, 22NW, LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 636,364 shares valued at US$1.6M.

Quarter by quarter

QuarterSharesValueChange
Q1 2025 636.36K $2.16M New
Q2 2025 636.36K $1.72M Hold
Q3 2025 636.36K $1.65M Hold
Q4 2025 636.36K $960.91K Hold
Q1 2026 636.36K $1.96M Hold
Q2 2026 636.36K $2.51M Hold
Q3 2026 636.36K $1.61M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELDN and 13F data

ELDN (ELEDON PHARMACEUTICALS INC) is a Health Care company. 37 other funds we track also report a position in ELDN — the largest reported positions include BVF INC/IL (US$24.8M), Defilade Capital Management, L.P. (US$13.9M), Catalio Capital Management, LP (US$6.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELDN

All ELDN fund holders →

FAQ

How long has 22NW, LP held ELDN?

22NW, LP has disclosed ELDN holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is 22NW, LP's current position in ELDN?

As of Q3 2026, 22NW, LP holds 636.36K shares of ELDN (ELEDON PHARMACEUTICALS INC), valued at $1.61M, representing 1.12% of its reported portfolio and ranking #13.

Has 22NW, LP been buying or selling ELDN?

In the latest 13F filing (Q3 2026), 22NW, LP held unchanged its position in ELDN. The position peaked in Q2 2026 at 636.36K shares.

Which other funds hold ELDN?

Other major institutional holders of ELDN include BVF INC/IL, Defilade Capital Management, L.P., Catalio Capital Management, LP, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.